ROMEO
Research type
Research Study
Full title
Rest Or Moderate mechanical ventilation during ECMO support
IRAS ID
351190
Contact name
Brijesh V Patel
Contact email
Sponsor organisation
Imperial College London
ISRCTN Number
ISRCTN70543115
Duration of Study in the UK
4 years, 3 months, 31 days
Research summary
Patients admitted to the intensive care unit with respiratory failure related to acute respiratory distress syndrome (ARDS) receive invasive mechanical ventilation. Mechanical ventilation is the medical term for a breathing machine used to assist or replace spontaneous breathing. Whilst this type of ventilation is a life-saving intervention, it can also cause lung damage if not implemented carefully. The ventilator forces a volume of air under pressure into the lungs like a bellows. Often the lungs of ARDS patients are already stiffer, and the ventilator can cause further damage by over pressuring and stretching part of the patient’s lungs. The patient will also be receiving extracorporeal membrane oxygenation (ECMO) as their lungs are severely injured and they cannot be oxygenated fully with conventional ventilation.
We know that if a ventilator is working hard to support a patient’s breathing it can slow or even harm their recovery, and it is better to provide more gentle support. We also know that ECMO allows us to provide this gentler mechanical ventilation to a patient by doing some, or all, of the work of their lungs.
It is not known whether it is better to provide ‘restful’ or ‘moderate’ support to a patient’s breathing.In order to understand which strategy is better, we need to randomly provide ‘restful’ or ‘moderate’ breathing support to patients who need to receive ECMO.
The purpose of this study is to evaluate the two different methods of providing mechanical ventilation to patients receiving ECMO.
They will receive this method of ventilation for the first three days on ECMO. On the fourth day, the patient’s ventilation technique will be decided by the doctors caring for the patient.The pathobiological, pathophysiological, and radiological processes involved in the progression and resolution of ARDS and VILI are poorly understood. The ROMEO study offers a unique opportunity to longitudinally assess and characterise the impact to near-apnoeic ventilation strategy on the clinical, physiological, and biological progression and resolution of ARDS supported on ECMO
REC name
London - Harrow Research Ethics Committee
REC reference
25/LO/0660
Date of REC Opinion
14 Oct 2025
REC opinion
Further Information Favourable Opinion